CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
1 Year Est. Return
+39.18%
AUM
$19.3B
AUM Growth
-$803M
(-4%)
Holding
738
Top Buys
| 1 | +$78.3M | |
| 2 | +$57M | |
| 3 | +$48M | |
| 4 |
Alibaba
BABA
|
+$43.4M |
| 5 |
Apple
AAPL
|
+$39M |
Top Sells
| 1 | +$87.5M | |
| 2 | +$45.5M | |
| 3 | +$44.5M | |
| 4 |
JPMorgan Chase
JPM
|
+$44.3M |
| 5 |
IQVIA
IQV
|
+$43M |
Sector Composition
| 1 | Technology | 32.73% |
| 2 | Healthcare | 27.11% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Datadog
DDOG
$95.8B
| $42.8M | 0.22% |
362,435
+67,418
|
|
||
102
HCA Healthcare
HCA
$81.5B
| $42.7M | 0.22% |
90,263
-10,738
|
|
||
103
Allstate
ALL
$54.2B
| $40.6M | 0.21% |
195,952
+61,172
|
|
||
104
Rhythm Pharmaceuticals
RYTM
$5.79B
| $40.4M | 0.21% |
464,340
+176,433
|
|
||
105
Nuvalent
NUVL
$7.22B
| $40.1M | 0.21% |
391,306
+33,293
|
|
||
106
Freeport-McMoran
FCX
$103B
| $39.9M | 0.21% |
679,498
+354,856
|
|
||
107
Targa Resources
TRGP
$56.5B
| $39.8M | 0.21% |
158,775
+134,866
|
|
||
108
Laureate Education
LAUR
$4.62B
| $39.8M | 0.21% |
1,142,109
-52,241
|
|
||
109
US Bancorp
USB
$84.7B
| $39.7M | 0.21% |
763,077
-14,219
|
|
||
110
argenx
ARGX
$49.9B
| $39.5M | 0.21% |
54,148
+5,407
|
|
||
|
111
IQVIA
IQV
$30.1B
| $38.7M | 0.2% |
226,794
-220,525
|
|
||
112
Tenet Healthcare
THC
$14.1B
| $38.1M | 0.2% |
202,158
+23,557
|
|
||
113
Credicorp
BAP
$27.3B
| $37.8M | 0.2% |
111,400
-39,800
|
|
||
114
Royal Bank of Canada
RY
$266B
| $37.4M | 0.19% |
232,260
+59,590
|
|
||
115
United Therapeutics
UTHR
$22.9B
| $37.4M | 0.19% |
63,066
-64,149
|
|
||
116
Comfort Systems
FIX
$66.3B
| $37.3M | 0.19% |
27,076
-1,210
|
|
||
117
Marriott International
MAR
$98.6B
| $37.3M | 0.19% |
114,132
+376
|
|
||
118
Synchrony
SYF
$23.9B
| $36.9M | 0.19% |
542,756
+35,967
|
|
||
119
IDEAYA Biosciences
IDYA
$2.45B
| $36.9M | 0.19% |
1,107,708
+76,354
|
|
||
120
CG Oncology
CGON
$4.9B
| $36.7M | 0.19% |
542,036
-255,579
|
|
||
121
Credo Technology Group
CRDO
$42.2B
| $36.5M | 0.19% |
389,106
+87,119
|
|
||
122
W.P. Carey
WPC
$16.4B
| $36.5M | 0.19% |
537,187
-4,036
|
|
||
123
Ionis Pharmaceuticals
IONS
$12.1B
| $36.3M | 0.19% |
484,053
-193,576
|
|
||
124
Neurocrine Biosciences
NBIX
$15.6B
| $36.2M | 0.19% |
275,064
-18,032
|
|
||
125
Idexx Laboratories
IDXX
$43.5B
| $36M | 0.19% |
64,015
+13,456
|
|